Finance

Lists
FN3:FRA
Racura Oncology Ltd
€1.26
+0.80%
(+0.0100) 1D
Sep 7, 9:55:01 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for FN3...
Open
€1.26
High
€1.26
Low
€1.26
Mkt. cap
417.63M
Avg. vol.
0.00
Volume
0.00
52-wk high
€2.64
52-wk low
€0.74
Open
€1.26
High
€1.26
Low
€1.26
Mkt. cap
417.63M
Avg. vol.
0.00
Volume
0.00
52-wk high
€2.64
52-wk low
€0.74
About Racura Oncology Ltd
CEODaniel Tillett
Employees-
Founded2011
Headquarters-
SectorBiotechnology
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.41M
1.41M
-
-
Cost of goods sold
127.77K
127.77K
417.22K
417.22K
Cost of revenue
127.77K
127.77K
417.22K
417.22K
Research and development expenses
1.72M
1.72M
2.09M
2.09M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
507.80K
507.80K
1.13M
1.13M
Operating expense
2.84M
2.84M
3.23M
3.23M
Total operating expenses
2.96M
2.96M
3.64M
3.64M
Operating income
-1.56M
-1.56M
-3.64M
-3.64M
Other non operating income
-42.62K
-42.62K
-37.35K
-37.35K
EBT including unusual items
-2.05M
-2.05M
-3.49M
-3.49M
EBT excluding unusual items
-1.48M
-1.48M
-3.49M
-3.49M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
175.95K
175.95K
294.96K
294.96K
Net income
-2.05M
-2.05M
-3.49M
-3.49M
Net profit margin
-145.81%
-145.81%
-
-
Earnings per share
-
-
-
-
Interest and investment income
119.85K
119.85K
186.80K
186.80K
Interest expense
-
-
-
-
Net interest expenses
119.85K
119.85K
186.80K
186.80K
Depreciation and amortization charges
70.30K
70.30K
70.30K
70.30K
EBITDA
-1.49M
-1.49M
-3.57M
-3.57M
Gain or loss from assets sale
-
-
-266.00
-266.00
AI content may include mistakes. Learn more
Google apps